-
Biocon settles eye disease biosimilar dispute with US biotech Regeneron
16 Apr 2025 12:33 GMT
Bengaluru: Indian drug maker Biocon’s biosimilars arm Biocon Biologics has announced a settlement and license agreement for its eye disease drug Yesafili (aflibercept-jbvf), an interchangeable biosimilar of blockbuster therapy Eylea with its brand owner …
-
FDA approves Biocon Biologics’ bevacizumab biosimilar for cancer
11 Apr 2025 08:49 GMT
… differences between Jobevne and Avastin.
Biocon Biologics CEO and managing director … more treatment options to patients.”
Biocon Biologics has commercialised nine biosimilars … and licence agreement with Janssen Biotech, Janssen Sciences Ireland and Johnson …
-
Global Biotechnology Market Size to Reach USD 5,036.46 Bn by 2034, Growing at 12.5% CAGR, Says Healthcare Experts
10 Apr 2025 15:11 GMT
… initiatives to support biotechnology research and development. Biotechnology Market Trends
Rising … & Challenges in the Biotechnology Market
Regulatory Challenges: Several … immunotherapy.
In December 2024, Biocon Biologics announced that it received …
-
Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers
07 Apr 2025 10:48 GMT
Shares of biotechnology major Biocon Ltd slipped over 6% … filing dated April 4, Biocon stated that the fundraising … tightening liquidity in the biotech sector.
Pharmaceutical stocks witnessed … following suit.
Top pharma losers: Biocon, IPCA, Glenmark, Divi’s …
-
Bengaluru should be 'ashamed': Biocon boss compares city’s streets to Equador's. Netizens say don't go that far to notice
27 Mar 2025 09:21 GMT
Biocon’s founder, Kiran Mazumdar Shaw, … in India's biotechnology sector, leading Biocon, a globally recognized biopharmaceutical … -generation entrepreneur, she has transformed Biocon from an industrial enzymes company …
-
Biocon's psoriasis biosimilar matches efficacy profile of J&J's reference drug in Phase 3 Study
11 Mar 2025 08:50 GMT
Bengaluru: Biosimilars developer Biocon Biologics announced that … Global Head of Clinical Development, Biocon Biologics, said, “The positive … name Stelara by Janssen Biotech, a subsidiary of US … MD, Chief Medical Officer, Biocon Biologics.
According to the …
-
Biocon’s subsidiary Syngene acquires US biologics facility for $36.5 mn
11 Mar 2025 03:22 GMT
… ) and publicly listed subsidiary of Biocon, acquired its first biologics site … solution for global pharma and biotech customers.”
“This investment will enable …
-
Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis
07 Mar 2025 15:08 GMT
… active psoriatic arthritis.
About Biocon Biologics Limited:
Biocon Biologics Ltd. (BBL), … while improving healthcare outcomes.
Biocon Biologics has commercialized nine … to the Indian and global biotechnology and pharmaceuticals industries, increasing …
-
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
06 Mar 2025 13:11 GMT
… /index.html
About Biocon Biologics Limited:
Biocon Biologics Ltd. (BBL), … while improving healthcare outcomes.
Biocon Biologics has commercialized eight biosimilars … to the Indian and global biotechnology and pharmaceuticals industries, increasing …
-
Stocks To Watch: From Biocon to Ola Electric- Here’s a list of 10 stocks in news today
05 Mar 2025 02:20 GMT
… on March 05, 2025
Biocon
Biotechnology giant Biocon has secured final approvals from …
About
© 1995-2025